Mast Cell Activation Syndrome and the Skin: The Inside-Out, Outside-In Story No One's Telling

If you work in esthetics or skin wellness long enough, you start to recognize a certain kind of client. Their skin flushes for no clear reason. It stings with products that “shouldn’t” be irritating. It reacts to weather, to stress, to a new sunscreen, to nothing at all. They’ve often been through derm after derm, elimination diet after elimination diet, and they arrive at your chair using a word more and more of them have learned on their own: MCAS–short for Mast Cell Activation Syndrome.

Mast Cell Activation Syndrome has been gaining visibility in functional and integrative medicine circles, and for good reason — it’s a unifying explanation for a constellation of symptoms that conventional medicine has historically struggled to connect. But almost every conversation about MCAS centers on the gut, the nervous system, the immune system at large. The skin gets mentioned as a symptom site — flushing, hives, itching — and then the conversation moves on.

That’s a missed opportunity, and it’s one we think about constantly through a Nutritional Aesthetics® lens.

The skin isn’t just where MCAS shows up. It’s an organ with its own resident population of mast cells, its own nervous system crosstalk, and its own feedback loop with the mast cells working throughout the rest of the body. And — this is the part we really want practitioners to sit with — many of the very habits we’ve normalized in skincare and professional esthetics or medical aesthetics treatment rooms can keep those skin mast cells on high alert, which can keep the whole system looping.

This is a true inside-out, outside-in condition. Let’s walk through what MCAS is, what’s known about its causes, and then spend real time on the skin piece — the anatomy, the physiology, and the gentle-skin approach that can help break a cycle that’s rarely named out loud.

A quick note before we dive in: MCAS is a medical diagnosis that requires medical evaluation, lab work, and physician-directed treatment. Nothing here is intended to diagnose or treat MCAS. The goal is to give skin and wellness professionals the foundational knowledge to recognize the pattern, support clients within their scope of practice, and collaborate thoughtfully with the rest of a client’s care team.

What Is Mast Cell Activation Syndrome?

Mast cells are immune cells that live in nearly every tissue in the body, and they’re best known for the role they play in allergic reactions. When triggered, they degranulate — releasing histamine, tryptase, prostaglandins, leukotrienes, and a long list of cytokines that drive inflammation, vasodilation, and itch.¹ In a healthy system, this is a tightly regulated, protective response: a bee sting triggers a localized reaction and then resolves.

In MCAS, mast cells become inappropriately reactive. They aren’t necessarily increased in number (that’s more characteristic of mastocytosis, a related but distinct condition); instead, their activation threshold is lowered, so they degranulate in response to triggers that shouldn’t provoke much of a response at all — foods, temperature changes, fragrance, friction, hormonal shifts, even emotional stress.²

The current consensus diagnostic framework (sometimes called the Vienna or ECNM-AIM criteria) requires three things to confirm MCAS:

• Typical, recurrent mast cell activation symptoms affecting two or more organ systems at once
• A measurable rise in a validated mast cell mediator (most often serum tryptase) during a symptomatic episode compared with the person’s baseline
• And a clinical response to medications that block mast cell mediators or their effects.³ ⁴

In practice, many people living with chronic, lower-grade mast cell symptoms don’t neatly fit this episodic, anaphylaxis-adjacent picture, which is part of why MCAS remains underdiagnosed, debated among specialists, and frequently missed for years.⁵

What Does MCAS Actually Look Like?

Because mast cells are distributed throughout the body, MCAS symptoms tend to cut across multiple systems simultaneously, which is exactly what makes it so hard to pin down in a conventional, single-specialist model of care. The most frequently reported categories include:

• Skin: flushing, hives (urticaria), itching, swelling (angioedema), and dermatographism (skin that welts when scratched or lightly scraped)
• Cardiovascular: rapid heart rate, lightheadedness, and drops in blood pressure, sometimes to the point of fainting
• Gastrointestinal: bloating, cramping, diarrhea, nausea, and reflux
• Respiratory and naso-ocular: nasal congestion, wheezing, and watery or itchy eyes
• Neurological: headache, brain fog, and anxiety-like symptoms that track with physical flares rather than standing alone⁶ ⁷

What tends to confuse the picture clinically is that these symptoms are often episodic and shifting — a flare might look completely different from one month to the next — and they frequently overlap with conditions like postural orthostatic tachycardia syndrome (POTS) and hypermobile Ehlers-Danlos syndrome, though a confirmed causal relationship between MCAS and either condition hasn’t been firmly established in research using strict diagnostic criteria.⁸

What Causes Mast Cells to Misfire?

There’s rarely a single cause. Most clinicians researching MCAS describe it as a multifactorial, “last straw” condition layered on top of genetic predisposition. A few of the most discussed contributing factors include:

Genetic susceptibility. Variants affecting mast cell regulation, including hereditary alpha-tryptasemia (extra copies of the tryptase gene), are among the more established genetic associations with MCAS.

Gut dysbiosis and barrier permeability. The gut is one of the body’s largest mast cell reservoirs, and mast cells there act as immune sentinels at the interface between the microbiome and the rest of the body. When the gut lining is compromised — through dysbiosis, infection, or chronic inflammation — circulating endotoxins and microbial metabolites can lower the threshold for mast cell activation, and disruptions to the microbiome (from antibiotic use, cesarean delivery, or a highly processed diet) can establish a feed-forward loop that keeps mast cells primed.⁹ ¹⁰

Chronic infections and immune activation. Viral illness, tick-borne infections, and mold or biotoxin exposure are commonly reported triggers in patients who develop MCAS-type symptoms later in life rather than from childhood, suggesting an acquired, environmentally driven pathway distinct from primarily genetic cases.

Hormonal fluctuation. Estrogen has a documented relationship with mast cell reactivity, which is part of why MCAS symptoms often intensify around menstruation, perimenopause, or pregnancy.

Nervous system dysregulation and chronic stress. This is a piece we’ll come back to in detail, because it connects directly to the skin — the nervous system and mast cells are in constant, bidirectional communication, and a dysregulated stress response can itself become a chronic mast cell trigger.

The Skin’s Mast Cells: An Overlooked Chapter

Here’s where most MCAS conversations stop short. Skin symptoms are listed as an outcome of systemic mast cell activation, full stop. But the skin has its own dense, strategically positioned population of resident mast cells that do far more than cause hives — and understanding their physiology changes how we think about skincare for these clients entirely.

Here’s A Quick Skin Anatomy Refresher:

The epidermis is the skin’s outermost, avascular layer, built mainly of keratinocytes organized into the stratum corneum, stratum granulosum, stratum spinosum, and stratum basale.¹¹ Directly beneath it sits the dermis, a vascularized, innervated layer of connective tissue, with the papillary dermis forming the thin, cellular zone immediately at the dermal-epidermal junction — the literal border between the two layers.

Mast cells are concentrated right at that border.

Mapping studies of human skin have found mast cell density is highest immediately below the dermal-epidermal junction, tapering off as you move deeper into the dermis.¹² They’re not floating around at random, either — mast cells in the skin are anatomically paired with sensory nerve endings, sitting in close, repeated contact with the same nerve fibers that carry pain and itch signals to the brain.¹³ And critically, their development and maintenance depend on stem cell factor produced by keratinocytes in the layer just above them, which means skin mast cells are, quite literally, kept alive and functional by ongoing signaling from the epidermis.¹⁴ The skin barrier and the skin’s mast cells are not separate stories. They’re built to communicate.

What skin mast cells actually do:

Beyond the histamine release most people associate with mast cells, cutaneous mast cells:

• Act as first-responder sentinels of the innate immune system, sensing microbial and environmental threats at the skin surface
• Help regulate local blood vessel tone and permeability, which is part of why flushing and visible redness are such common mast cell “tells”
• Release IL-31 and other mediators that directly stimulate sensory nerve fibers, which is one of the core mechanisms behind chronic, unexplained itch¹⁵
• Influence keratinocyte function and tight junction integrity, meaning an overactive mast cell population can itself degrade the very barrier it’s supposed to help protect¹⁶
• Function as part of what researchers increasingly describe as an “epidermal-immune-neuro unit” — a three-way functional circuit between keratinocytes, immune cells (including mast cells), and cutaneous nerves that exists specifically to detect and respond to barrier threats¹⁷

The skin-to-body conversation:

Skin mast cells aren’t operating in isolation from systemic mast cells, either. They share the same mediator toolkit — histamine, tryptase, cytokines like IL-6 and TNF — and they respond to many of the same circulating triggers, including stress hormones and neuropeptides arriving from elsewhere in the body. When systemic mast cell activation is already running hot, the skin’s local mast cell population doesn’t get a pass; it’s primed right alongside everything else.

This is part of why skin flares in MCAS so often track with gut flares, hormonal shifts, or stress spikes — it’s one interconnected mast cell ecosystem, expressed in different tissues.

Stress, the Skin’s Own Internal Alarm System, and Mast Cells

This is the piece that ties psychological stress directly to skin reactivity, and it’s genuinely fascinating physiology.

The skin has its own local, functional equivalent of the hypothalamic-pituitary-adrenal (HPA) axis — the system most people associate purely with the brain and adrenal glands. Skin cells, including mast cells themselves, can produce corticotropin-releasing hormone (CRH) locally, and human skin mast cells express CRH receptors directly on their surface.¹⁸ ¹⁹ When a person experiences psychological stress, the resulting rise in CRH — both from the central HPA axis and from local skin production — binds to those receptors and activates the mast cells sitting in the dermis, increasing vascular permeability and triggering the release of inflammatory mediators.²⁰

This doesn’t happen in isolation from the nervous system, either. Psychological stress also drives the release of substance P and other neuropeptides from sensory nerve fibers in the skin, which independently activate nearby mast cells. The activated mast cells, in turn, release mediators that further sensitize those same nerve fibers — a reciprocal loop researchers describe explicitly as a “vicious circle” capable of sustaining and amplifying neurogenic skin inflammation well beyond the original stressor.²¹ ²² Mast cells have been described as occupying a “central switchboard position” in the skin’s stress response — they’re simultaneously a target of stress signaling and an active driver of the inflammation that follows.²³

For clients with MCAS, this means stress isn’t just an aggravating factor that makes them feel worse. It’s a direct, biochemical mast cell trigger acting through a pathway that lives in the skin itself.

The Cycle Nobody’s Talking About: How Skincare Habits Keep Skin Mast Cells On Alert

Now for the part that’s most relevant to Nutritional Aesthetics and the work happening in treatment rooms every day.

The outermost barrier of the skin — the stratum corneum’s lipid matrix of ceramides, cholesterol, and fatty acids, sitting at a naturally acidic pH of roughly 4.5 to 5.5 — exists to keep water in and irritants out.²⁴ When that barrier is compromised, two things happen at once: transepidermal water loss increases, and the skin becomes more permeable to whatever was trying to get in. Surfactant-based cleansers, especially those built around anionic surfactants like sodium lauryl sulfate, are a well-studied model of exactly this kind of disruption — they strip lipids from the stratum corneum, denature proteins, and shift skin pH upward, all of which compounds the irritation rather than resolving independently.²⁵ ²⁶ Stratum corneum cytokine studies confirm that this kind of surfactant exposure provokes a measurable local irritation response, not just a cosmetic, surface-level dryness.²⁷

Here’s the connection that rarely gets made explicit: that irritation response isn’t happening to the skin in some abstract sense. It’s happening to the mast cells living right at that dermal-epidermal border. A landmark study using human mast cells found that substance P — the same neuropeptide released during stress and tissue injury — triggers mast cell histamine and cytokine release through a receptor pathway that doesn’t require an allergen or IgE antibody at all.²⁸ This is part of a broader mechanism known as MRGPRX2-mediated activation, which allows mast cells to be triggered directly by physical and chemical insults, independent of true allergy — and it’s increasingly recognized as relevant to chronic, hard-to-explain skin reactivity and conditions like chronic urticaria.²⁹ In a related clinical study, researchers showed that sodium-lauryl-sulfate-induced skin irritation could be meaningfully reduced with an oral mast cell-stabilizing flavonoid, quercetin — direct evidence that a “simple” surfactant irritation is, at least in part, a mast cell-mediated event.³⁰

Now stack the rest of the habits many clients (and unfortunately, many protocols) layer on top: over-cleansing, the wrong-pH products, fragrance and other known sensitizers, frequent chemical peels, microdermabrasion, and aggressive laser treatments performed without adequate barrier recovery time in between. Each of these is, mechanistically, another barrier-disruption event. And the skin’s own research-backed feedback loop tells us what happens next: barrier impairment lets irritants and allergens penetrate more deeply, which causes keratinocytes to release alarm signals (TSLP, IL-33, IL-25) that directly activate both mast cells and sensory nerves, which causes more inflammation and itch, which damages the barrier further.³¹ It’s a self-perpetuating loop — and for someone whose mast cells are already hyper-reactive systemically, a topical regimen that keeps re-triggering this cycle isn’t a neutral, separate issue from their MCAS. It’s actively feeding it.

This is the piece we want every Certified Nutritional Aesthetics Practitioner, esthetician, aesthetic nurse, health coach, and functional practitioner reading this to internalize: for an MCAS client, “more active,” “more frequent,” and “more intensive” are very rarely the right direction. The skin is asking, quite literally at the cellular level, to be taken out of a state of hypervigilance.

Breaking the Cycle: A Nutritional Aesthetics® Approach

Because MCAS is a whole-body, whole-nervous-system condition that happens to show up vividly in the skin, supporting it well requires working inside out and outside in, together. Here’s a foundational framework — always to be adapted to the individual, their full health history, and your specific scope of practice.

Inside Out: Nutrition Foundations

A foundational, anti-inflammatory, whole-foods approach is the starting point for almost every MCAS client, though the specifics need to be individualized. Many practitioners begin with a low-histamine framework — not as a permanent restriction, but as a way to lower the overall mediator load while other root causes are addressed, since fresh, unprocessed foods are generally far lower in histamine than aged, fermented, leftover, or long-simmered foods like bone broth.³²

From there, building back in quercetin-rich foods (onions, apples, capers, leafy greens), vitamin-C-rich produce (bell peppers, citrus, berries), and anti-inflammatory omega-3 sources (fatty fish, walnuts, flax) gives the body raw material to both stabilize mast cells and break down the histamine they do release.

Inside Out: Foundational Supplement Considerations

These are commonly discussed in functional and integrative MCAS care, always best implemented in collaboration with a client’s physician or qualified healthcare provider:

• Quercetin, a plant flavonoid shown in human mast cell research to inhibit histamine, cytokine, and leukotriene release more effectively than the pharmaceutical mast cell stabilizer cromolyn, with documented benefit for contact dermatitis and skin photosensitivity in clinical pilot studies³³
• Vitamin C, which supports diamine oxidase (DAO) — the primary enzyme responsible for breaking down dietary histamine — while also acting as a mast cell-supportive antioxidant³⁴
• Vitamin B6 and copper, both essential cofactors for DAO enzyme production and function³⁵
• Magnesium, which has a documented relationship with DAO activity and is broadly supportive of nervous system regulation
• Omega-3 fatty acids, to help lower systemic inflammatory tone and support gut barrier integrity

Inside Out: Stress Management and Nervous System Regulation

Given everything we now understand about CRH, substance P, and the skin’s local stress-response circuitry, nervous system regulation isn’t a “nice to have” for MCAS clients — it’s foundational mast cell management. Practices that downregulate sympathetic tone and support a sense of physiological safety include slow, extended-exhale breathwork, regular gentle movement (walking, restorative yoga, swimming), consistent sleep timing, time in nature, and — where appropriate — working with a trauma-informed therapist or somatic practitioner, particularly given how often chronic MCAS develops alongside a history of significant physiological or psychological stress.

Inside Out: Lifestyle Foundations

Rounding out the inside-out picture: prioritizing consistent, adequate sleep (during which much of the body’s anti-inflammatory regulation happens), reducing exposure to environmental toxins and mold where possible, supporting gut healing through professional guidance rather than aggressive self-directed protocols, and pacing any new intervention slowly, one variable at a time, so a flare can actually be traced back to its trigger.

Outside In: The Gentle Skin Approach

This is where Nutritional Aesthetics® closes the loop. If skin mast cells are activated by barrier disruption, and barrier disruption is so often driven by well-intentioned but overly aggressive skincare, then the outside-in protocol for an MCAS client should be built around one organizing principle: calm the hypervigilance, don’t provoke it further.

Nourish and hydrate first. Lean on barrier-supportive formulations — ceramides to physically replenish the lipid matrix, alongside humectants and emollients that restore hydration without introducing friction or chemical stress. The goal is recovery, not transformation.

Protect consistently. A compromised barrier is more vulnerable to UV and environmental stress, and UV exposure itself is a documented mast cell and skin-photosensitivity trigger.³⁶ Daily, mineral-forward sun protection belongs in every MCAS skin protocol.

Keep cleansing light. Favor low-foam, pH-balanced, fragrance-free cleansers, used once daily where tolerated rather than twice, and skip the double-cleanse for clients in an active flare. The goal is removing what needs to be removed without re-stripping the lipid matrix every single day.

Hold the actives. Chemical exfoliants, retinoids, high-percentage vitamin C, and other typically beneficial actives are, for this population, often doing more harm than good while the barrier is compromised — they each independently elevate transepidermal water loss and can re-trigger the same irritation cascade described above. These can often be reintroduced later, slowly, once the barrier has had real time to recover.

Use gentle facial massage and lymphatic support thoughtfully. Manual lymphatic drainage techniques — slow, light-pressure, rhythmic strokes — are used clinically to support local fluid movement and reduce tissue congestion, and many practitioners report they help reduce a sense of facial puffiness and support overall comfort.³⁷ The evidence base specifically for facial aesthetic outcomes is still developing, so it’s worth framing this with clients as a supportive, calming modality rather than a guaranteed clinical fix — but the rationale of supporting circulation and easing tissue congestion fits naturally within a gentle, non-provoking protocol.

Reconsider the cadence of in-clinic procedures. Chemical peels, microdermabrasion, and laser treatments all work, by design, through controlled barrier disruption. For most clients, the skin recovers and rebuilds stronger. For a client with hyperreactive mast cells, that same controlled disruption can be the spark that sets off a flare that lasts well beyond the treatment itself. This doesn’t mean these modalities are permanently off the table — but it does mean longer recovery windows between treatments, lower intensities, thorough patch testing, and close communication with the client about how their skin (and their broader MCAS symptoms) responded before scheduling the next one.

Bringing It Together

MCAS is, at its core, a story about a nervous and immune system that has lost its sense of “all clear.” The skin isn’t a passive bystander in that story — it’s an active participant, with its own mast cells, its own nerve connections, and its own miniature stress-response system, all wired directly into the same hypervigilance loop playing out in the gut, the cardiovascular system, and the brain. Supporting a client through MCAS without addressing how their skincare routine and in-clinic treatments are affecting that loop is, at best, an incomplete picture.

This is exactly the kind of root-cause, whole-person pattern recognition that Nutritional Aesthetics® was built to train practitioners to see — the ability to look at a client’s skin and ask not just “what product fixes this,” but “what is this skin telling me about everything else going on in this body, and how do I support all of it together.”

If this kind of integrative thinking is the way you want to practice — for clients navigating complex conditions like MCAS, and for the everyday skin goals you already work with — we’d love for you to learn more about how to support clients with a truly integrative approach.

Check out our Certified Nutritional Aesthetics Practitioner® (CNAP) Training Program to see how we train practitioners to work with skin from the inside out and outside in.

References

1. Castells M, et al. Mast cell mediators in allergic inflammation and mastocytosis-related research, as referenced in Weng Z, et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans. PLoS ONE. 2012;7(3):e33805.
2. Mast cell activation syndrome: an up-to-date review of literature. PMC. 2024.
3. Akin C, Valent P, Metcalfe DD. Mast cell activation syndrome: Proposed diagnostic criteria. J Allergy Clin Immunol. 2010;126(6):1099-1104.
4. Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review. J Allergy Clin Immunol Pract. 2021.
5. Using the Right Criteria for MCAS. Curr Allergy Asthma Rep, via PMC. 2024.
6. Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach. PMC. 2025.
7. Mast cell activation syndrome: an up-to-date review of literature. PMC. 2024.
8. Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach. PMC. 2025.
9. The Gut Microbiota–Mast Cell Axis in Intestinal Homeostasis and Food Allergy Pathogenesis. PMC. 2025.
10. Dysbiosis of the Gut Microbiome Associated With Mast Cell Activation in Systemic Mastocytosis. J Allergy Clin Immunol, via Rare Disease Advisor. 2025.
11. Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States. Front Immunol. 2021.
12. Distribution of mast cells in human dermis: development of a mapping technique. Br J Dermatol. 1979;100(6):635.
13. Soluble mediators in the function of the epidermal-immune-neuro unit in the skin. Front Immunol. 2022.
14. Soluble mediators in the function of the epidermal-immune-neuro unit in the skin. Front Immunol. 2022.
15. The recent advances of mast cells in the pathogenesis of atopic dermatitis. Front Allergy. 2025.
16. The recent advances of mast cells in the pathogenesis of atopic dermatitis. Front Allergy. 2025.
17. Soluble mediators in the function of the epidermal-immune-neuro unit in the skin. Front Immunol. 2022.
18. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol. 2006.
19. Theoharides TC, et al. The impact of psychological stress on mast cells. Ann Allergy Asthma Immunol. 2020.
20. Theoharides TC, et al. The impact of psychological stress on mast cells. Ann Allergy Asthma Immunol. 2020.
21. Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation. Front Cell Neurosci. 2019.
22. Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis. PMC. 2012.
23. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol. 2006.
24. The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair. Skin Pharmacol Physiol. 2023.
25. The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair. Skin Pharmacol Physiol. 2023.
26. Methods for Assessing Skin Barrier Integrity: Effects of Cleansing Products. Plastic Surgery Key reference compendium.
27. Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate, as referenced in The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair. Skin Pharmacol Physiol. 2023.
28. Weng Z, Zhang B, Asadi S, et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans. PLoS ONE. 2012;7(3):e33805.
29. Pharmacological blockade of the mast cell MRGPRX2 receptor supports investigation of its relevance in skin disorders. PMC. 2024.
30. Katsarou A, Davoy E, Xenos K, Armenaka M, Theoharides TC. Effect of an antioxidant (quercetin) on sodium-lauryl-sulfate-induced skin irritation. Contact Dermatitis. 2000;42:85-89.
31. Mast cell–neuron axis as a core mechanism in chronic pruritus of atopic dermatitis: from mechanistic insights to therapeutic targets. Front Immunol. 2025.
32. Low-Histamine Diet for MCAS: Foods to Eat and Foods to Avoid. RTHM. 2026.
33. Weng Z, Zhang B, Asadi S, et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans. PLoS ONE. 2012;7(3):e33805.
34. Supplements and MCAS. Mast Cell Action.
35. Functional Medicine Approach to Low Histamine Diet and Its Connection to MCAS and DAO. Toronto Integrative & Functional Medicine. 2024.
36. Weng Z, Zhang B, Asadi S, et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans. PLoS ONE. 2012;7(3):e33805.
37. What is a Lymphatic Facial and Is It Worth It? Face Beauty Science. 2025.

This article is intended for educational purposes for skin and wellness professionals and is not a substitute for medical diagnosis or treatment. MCAS is a medical condition requiring evaluation by a qualified healthcare provider.